Your trusted source for investing success

Tag: leadership team

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 

David Kendall Joins MannKind as Chief Medical Officer

MannKind (NASDAQ:MNKD) today announced that David M. Kendall, MD, will join the company as Chief Medical Officer and assume full responsibility for leading MannKind’s scientific research, clinical development, regulatory, and medical affairs activity, effective February 12.

As quoted in the press release:
“David is a world renowned diabetes expert and represents an important addition

Voyager Therapeutics Announces CEO Succession Plan for 2018

Voyager Therapeutics (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases announced plans during 2018 for Steven Paul, M.D., to transition from president and chief executive officer of Voyager Therapeutics to executive science advisor.

As quoted in the press release:
“Steve has been an integral part

Supreme Continues to Strengthen Leadership Team for Growth

Supreme Continues to Strengthen Leadership Team for Growth

The Supreme Cannabis Company, Inc. (TSXV:FIRE) is pleased to announce the addition of Ms. Sony Gokhale, BBA, LLB, as the Company’s General Counsel.  Ms. Gokhale was most recently a senior member of the Commercial and Technology group at Osler, Hoskin & Harcourt, LLP in Toronto, Ontario.

“Our business is driven by a commitment to

Kinaxis Reports Fiscal Third Quarter 2017 Results

Kinaxis (TSX:KXS) has announced its third quarter results, ended September 30, 2017.

As quoted in the press release:

Third Quarter 2017 Highlights 

(Comparisons made between fiscal Q3 2017 and fiscal Q3 2016 results, unless otherwise noted)

Revenue totaled $33.5 million, up 12%
Subscription revenue was $25.8 million, up 24%
Gross profit was $23.8 million (71% of total

BioSig Technologies Partners with Sherpa Technology Group

BioSig Technologies Partners with Sherpa Technology Group

BioSig Technologies, Inc. (OTCQB:BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has hired Sherpa Technology Group as its Intellectual Property Advisor.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Pharmaceutical NASDAQ Micro-Cap Stocks

URL: https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/pharma-micro-cap-stocks-nasdaq/